TGen Tech, LLC
Decellularized, pentagalloyl glucose-stabilized bovine jugular vein valved conduit for congenital heart disease repair
- Sector
- Medtech
- Headquarters
- Alpharetta, GA
- Founded
- 2018
- Latest Form D
- $300K, Dec 2020
- Total capital
- $2.5M
- Federal grants
- $2.2M
- 2 awards · 2020–2021
- Rank in peer group#525 of 538
- Private capital raised
- $300K
- 1 Form D · last Dec 2020
- 71 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 2 pending · first 2026
- Rank in peer group#237 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Pulmonary valved conduit xenograft with regeneration potential$1.9M
- Private capital raisedForm D · SEC · 1st filing$300K
- Federal grantHealth and Human S · Phase I · Decellularized xenograft leaflet patch for pulmonary valve repair in pediatric patients$328K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
2months
from TGen Tech, LLC’s first federal award to its first private round.
- First federal award · Sep 2020
- Health and Human S · $328K
- First Form D · Dec 2020
- $300K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#237 · top 44%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ajay HoudeResearcherExecutive Officer, DirectorLinked by $1.9M in grants as PI
- Naren VyavahareResearcherExecutive Officer, DirectorLinked by $328K in grants as PI
What it has protected
USPTO · 1 granted of 3- GrantedSystems and Methods for Processing TissueUSPTOUS 12,570,954
- PendingSystems And Methods For Processing TissueUSPTOApplication PCTUS2021071375
- PendingSystems and Methods for Processing TissueUSPTOApplication 63075048
Related companies, and why
- ENDOTHEIA INCSimilar federal contract value in Medtech · null in contracts
- GYNION, LLCSimilar federal contract value in Medtech · null in contracts
- SCIKON INNOVATION, INC.Similar federal contract value in Medtech · null in contracts
- DIATECH DIABETES, INC.Similar federal contract value in Medtech · null in contracts
- VON MEDICAL, INCSimilar federal contract value in Medtech · null in contracts
- Autus Valve Technologies, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .